Institutional investors purchased a net $6.4 million shares of OMER during the quarter ended March 2015, and now own 58.73% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
LIFESCI INDEX PARTNERS LLC Bought 912.00 shares of Omeros Corp
STATE STREET GLOBAL ADVISORS LTD... Bought 236.00 shares of Omeros Corp
APO ASSET MANAGEMENT GMBH Sold 6.0 Thousand shares of Omeros Corp